KAT7 and hepatocellular carcinoma: found that MiR‐639 is complementary to sequences in the 3′ untranslated regions of HBO1, targeting HBO1 expression and thereby downregulating the HBO1‐mediated Wnt/β‐catenin pathway to inhibit the malignant capacity of HCC cells.231